Dexamethasone reduces glycolysis and inflammation in human macrophages infected with Mycobacterium avium without compromising bacterial control.
Data files
Aug 05, 2026 version files 192.01 KB
-
README.md
10.83 KB
-
Thong_JID_DRYAD_File_2026_Fig1A.csv
31.14 KB
-
Thong_JID_DRYAD_File_2026_Fig1B.csv
8.93 KB
-
Thong_JID_DRYAD_File_2026_Fig1C.csv
1.02 KB
-
Thong_JID_DRYAD_File_2026_Fig1D.csv
1.02 KB
-
Thong_JID_DRYAD_File_2026_Fig1E.csv
956 B
-
Thong_JID_DRYAD_File_2026_Fig1F.csv
33.35 KB
-
Thong_JID_DRYAD_File_2026_Fig1G.csv
1.96 KB
-
Thong_JID_DRYAD_File_2026_Fig1H.csv
1.96 KB
-
Thong_JID_DRYAD_File_2026_Fig1I.csv
1.96 KB
-
Thong_JID_DRYAD_File_2026_Fig1J.csv
1.96 KB
-
Thong_JID_DRYAD_File_2026_Fig1K.csv
8.36 KB
-
Thong_JID_DRYAD_File_2026_Fig1L.csv
2.73 KB
-
Thong_JID_DRYAD_File_2026_Fig1M.csv
2.73 KB
-
Thong_JID_DRYAD_File_2026_Fig1N.csv
3.43 KB
-
Thong_JID_DRYAD_File_2026_Fig1O.csv
7.05 KB
-
Thong_JID_DRYAD_File_2026_Fig1P.csv
7.18 KB
-
Thong_JID_DRYAD_File_2026_Fig1Q.csv
7.25 KB
-
Thong_JID_DRYAD_File_2026_Fig1R.csv
3.28 KB
-
Thong_JID_DRYAD_File_2026_Fig1S.csv
7.39 KB
-
Thong_JID_DRYAD_File_2026_Fig1T.csv
1.68 KB
-
Thong_JID_DRYAD_File_2026_Fig1U.csv
1.69 KB
-
Thong_JID_DRYAD_File_2026_Fig1V.csv
1.69 KB
-
Thong_JID_DRYAD_File_2026_Fig1W.csv
1.82 KB
-
Thong_JID_DRYAD_File_2026.xlsx
40.63 KB
Abstract
Nontuberculous mycobacterial infections are associated with persistent inflammation and prolonged treatment, yet host-directed therapeutic strategies remain lacking. Using metabolic flux analysis, we show dexamethasone suppresses Mycobacterium avium-induced glycolysis in human monocyte derived macrophages (MDM). Furthermore, dexamethasone reduced metabolic enzyme expression and pro-inflammatory cytokines, without affecting bacterial control in human macrophages. These findings indicate that suppression of glycolytic metabolism can occur without impacting bacterial control in human macrophages and supports further investigation of dexamethasone as a potential host-directed strategy to limit inflammation while preserving host defence in nontuberculous mycobacterial disease.
Dataset DOI: 10.5061/dryad.k98sf7mnv
Description of the data and file structure
All data was generated from human monocyte derived macrophages infected with Mycobacterium avium subsp. hominissuis 104 (MAH 104) strain.
Files and variables
File: Thong_JID_DRYAD_File_2026.xlsx
The data is presented in an Excel file. All data was anonymised and relabelled after analysis starting at Donor 1 etc. and as such any data from a given donor can be matched throughout the data set. It is highly recommended to read the Excel file in conjunction with the associated paper. The data has been organised based on the layout of figures in the associated paper published in the Journal of Infectious Disease.
For the Excel file the outputs are listed in columns F or AA. These outputs correspond to subparts of figure 1, i.e. Fig 1A, 1B etc. in the accompanying paper in the Journal of Infectious Disease. The Excel workbook preserves the original figure-oriented layout used for the associated manuscript for ease of cross referencing for readers of the manuscript.
Corresponding CSV files contain the same underlying data in machine-readable format for reuse and re-analysis. Labelled Thong JID DRYAD File 2026 Fig1A, Thong JID DRYAD File 2026 Fig1B etc.
All cells used to generate the data are human monocyte derived macrophages and are infected with Mycobacterium avium subsp. hominissuis 104.
Excel Sheet 1 (Figure 1):
Data is derived from human monocyte derived macrophages (MDM) that were treated with vehicle control (VC; ethanol 0.02%) or dexamethasone (0.5 or 5 µM) for 20 min prior to infection with M. avium and analysis in the Seahorse XFe24 Analyzer using a glycolytic rate assay (A-F). Alternatively, human MDM were treated with VC or dexamethasone for 1 hours, infected with M. avium lysed and RNA extracted. The expression of mRNA transcripts of metabolic enzymes were assessed to support the functional metabolic data (G-J). Mycobacterial growth was examined in dexamethasone treated macrophages by colony forming unit assay (K-L). Cell death was assessed in uninfected or M. avium infected MDM in the absence or presence of dexamethasone (N). Finally, ability of dexamethasone to alter the secretion of cytokines TNF, IL-6, IL-8, IL-1β and IL-10 was assessed in supernatants from M. avium infected MDM (O-S). The expression of mRNA transcripts of NADPH oxidase subunits were assessed to support the CFU data (T-W).
Outputs within the data:
Glyco Proton Extrusion Rate (GlycoPER; pmol/min), a marker of glycolysis. This output relates to Figure 1A, 1B, 1C, and 1D of the associated paper.
Oxygen Consumption Rate (OCR, pmol/min), a surrogate marker of oxidative phosphorylation. This output relates to Figure 1E, and 1F of the associated paper.
Gene expression relative to 18S (fold change to infected control) for PFKFB3, GAPDH and PKM2. These are genes encoding for glycolytic enzymes. This output relates to Figure 1G-I of the associated paper.
Gene expression relative to 18S (fold change to infected control) for ATP5B. This is a gene encoding an enzyme required for oxidative phosphorylation. This output relates to Figure 1J of the associated paper.
Colony Forming Units (CFU) per mL (CFU/mL) were used to measure bacterial growth from infected macrophages. This output relates to Figures 1K, 1L and 1M of the associated paper.
Cell Death calculated as a percentage (%) of total cells. This output relates to Figure 1N of the associated paper.
Secreted levels of TNF, IL-6, IL-8, IL-1β and IL-10 are reported as picogram per mL (pg/mL) and were assayed by ELISA. This output relates to Figure 1O-R of the associated paper.
Gene expression relative to 18S (fold change to infected control) for CYBB, CYBA, NCF1 and NCF2. These genes encode for subunits of the NADPH oxidase enzyme complex. This output relates to Figure 1T-W of the associated paper.
Figure 1A
- Thong_JID_DRYAD_File_2026_Fig1A.csv
Time-course of a Seahorse glycolytic rate assay measuring GlycoPER of human monocyte-derived macrophages (MDM) treated with vehicle control (VC), dexamethasone 0.5 μM, or dexamethasone 5 μM and infected in realtime with M. avium after the 4th reading during the assay. GlycoPER (pmol/min) is a measure of cellular glycolytic activity.
Figure 1B
- Thong_JID_DRYAD_File_2026_Fig1B.csv
Average induced glycolysis was calculated from the Seahorse time-course in Figure 1A, post infection with M. avium and prior to the addition of inhibitors to conduct the glycolytic rate assay. Values are reported as GlycoPER (pmol/min).
Figure 1C
- Thong_JID_DRYAD_File_2026_Fig1C.csv
Maximum induced glycolysis was derived from the final reading before the addition of inhibitors to conduct the glycolytic rate assay in Figure 1A. Values are reported as GlycoPER (pmol/min).
Figure 1D
- Thong_JID_DRYAD_File_2026_Fig1D.csv
Compensatory glycolysis calculated from the Seahorse Glycolytic Rate Assay shown in Figure 1A. Compensatory glycolysis represents the ability of cells to increase glycolysis in response to loss of mitochondrial ATP production by blockade using rotenone and antimycin A during the Glycolytic Rate Assay. Values are reported as GlycoPER (pmol/min).
Figure 1E
- Thong_JID_DRYAD_File_2026_Fig1E.csv
Induced oxygen consumption rate (OCR) was calculated from the reading post infection with M. avium to the reading immediately prior to addition of inhibitors to conduct the glycolytic rate assay. Data is derived from the time-course in figure 1F. OCR is a surrogate measure of oxidative phosphorylation and is reported in pmol/min.
Figure 1F
- Thong_JID_DRYAD_File_2026_Fig1F.csv
Time-course OCR measurements obtained during Seahorse analysis. OCR is reported in pmol/min.
Figure 1G
- Thong_JID_DRYAD_File_2026_Fig1G.csv
Expression of the glycolytic enzyme gene PFKFB3 in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Figure 1H
- Thong_JID_DRYAD_File_2026_Fig1H.csv
Expression of the glycolytic enzyme gene GAPDH in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Figure 1I
- Thong_JID_DRYAD_File_2026_Fig1I.csv
Expression of the glycolytic enzyme gene PKM2 in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Figure 1J
- Thong_JID_DRYAD_File_2026_Fig1J.csv
Expression of ATP5B, a gene involved in oxidative phosphorylation, in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Figure 1K
- Thong_JID_DRYAD_File_2026_Fig1K.csv
Bacterial burden measured as colony-forming units per millilitre (CFU/mL) at 3 h, 48 h and 120 h after M. avium infection in the presence or absence of dexamethasone.
Figure 1L
- Thong_JID_DRYAD_File_2026_Fig1L.csv
CFU/mL values at 48 h post-infection extracted from Figure 1K for statistical comparison.
Figure 1M
- Thong_JID_DRYAD_File_2026_Fig1M.csv
CFU/mL values at 120 h post-infection extracted from Figure 1K for statistical comparison.
Figure 1N
- Thong_JID_DRYAD_File_2026_Fig1N.csv
Percentage cell death in uninfected or Mycobacterium avium-infected macrophages treated with vehicle control or dexamethasone.
Figure 1O
- Thong_JID_DRYAD_File_2026_Fig1O.csv
TNF secretion in supernatants of uninfected or Mycobacterium avium-infected human MDM, in the presence or absence of dexamethasone measured by ELISA. The data is reported as pg/mL.
Figure 1P
- Thong_JID_DRYAD_File_2026_Fig1P.csv
IL-6 secretion in supernatants of uninfected or Mycobacterium avium-infected human MDM, in the presence or absence of dexamethasone measured by ELISA. The data is reported as pg/mL.
Figure 1Q
- Thong_JID_DRYAD_File_2026_Fig1Q.csv
IL-8 secretion in supernatants of uninfected or Mycobacterium avium-infected human MDM, in the presence or absence of dexamethasone measured by ELISA. The data is reported as pg/mL.
Figure 1R
- Thong_JID_DRYAD_File_2026_Fig1R.csv
IL-1β secretion in supernatants of uninfected or Mycobacterium avium-infected human MDM, in the presence or absence of dexamethasone measured by ELISA. The data is reported as pg/mL.
Figure 1S
- Thong_JID_DRYAD_File_2026_Fig1S.csv
IL-10 secretion in supernatants of uninfected or Mycobacterium avium-infected human MDM, in the presence or absence of dexamethasone measured by ELISA. The data is reported as pg/mL.
Figure 1T
- Thong_JID_DRYAD_File_2026_Fig1T.csv
Expression of the NADPH oxidase subunit CYBB in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Figure 1U
- Thong_JID_DRYAD_File_2026_Fig1U.csv
Expression of the NADPH oxidase subunit CYBA in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Figure 1V
- Thong_JID_DRYAD_File_2026_Fig1V.csv
Expression of the NADPH oxidase subunit NCF1 in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Figure 1W
- Thong_JID_DRYAD_File_2026_Fig1W.csv
Expression of the NADPH oxidase subunit NCF2 in M. avium infected human MDM treated with dexamethasone and measured by qPCR. The data is reported as fold change relative to M. avium infected controls.
Abbreviations
- VC: Vehicle Control
- Dex: Dexamethasone
- MDM: Monocyte-Derived Macrophages
- MAH: Mycobacterium avium subsp. hominissuis
- GlycoPER: Glycolytic Proton Efflux Rate
- OCR: Oxygen Consumption Rate
- CFU: Colony Forming Unit
- TNF: Tumour Necrosis Factor
- IL: Interleukin
- qPCR: Quantitative Polymerase Chain Reaction
Human subjects data
All individuals provided written informed consent and were made aware that collective results arising from samples given would be published. Each donor was assigned an anonymized, sequential identification number (starting at 1) after data analysis and graphing. These identifiers are arbitrary and cannot be linked to any personal information, ensuring complete anonymisation.
Human Macrophage Culture and Infection
PBMC were isolated from buffy coats obtained with consent from the Irish Blood Transfusion Service (IBTS; ethical approval, School of Medicine Research Ethics Committee, Trinity College Dublin) and monocyte derived macrophages (MDM) were adherence purified and differentiated using 10 % human AB serum. MDM were treated with vehicle (ethanol, 0.02 %) or dexamethasone (0.5-5 μM), prior to infection with Mycobacterium avium subsp. hominissuis 104 (MAH 104) strain. The multiplicity of infection (MOI) and donor variation in phagocytosis of M. avium was determined and adjusted by Auramine-O staining. MDM were plated on 8-well Lab-Tek chamber slides (Nunc) and infected with a range of bacterial concentrations for 3 h before extracellular bacteria were thoroughly washed off. Cells were fixed with 2 % PFA, stained with rapid Auramine O staining set (Scientific Device Laboratory Inc). The numbers of bacilli per cell were counted with a fluorescent microscope (Olympus IX51) and this was used to calculate an MOI with a range of 1–10 bacteria per cell for all experiments (~60-70 % of macrophages infected with at least 1 bacillus; average 2–5, median 1-4 bacilli per cell, maximum of 10 bacteria per cell).
Metabolic Flux Analysis
MDM (1x105 cells/well) were cold lifted using ice cold PBS and re-plated onto 8-well Seahorse plates (Agilent). MDM were monitored in real-time using a Seahorse XFp Analyzer and the oxygen consumption rate (OCR) and the glycolytic proton efflux rate (GlycoPER; determined using a glycolytic rate assay) were recorded.
Gene Expression Analysis
RNA extractions from MDM were performed using an RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. RNA content and quality were quantified and assayed using a Nanodrop (Thermo Fisher Scientific) and RNA reverse transcribed using the SensiFast Reverse-Transcription Kit (Meridian Biosciences). Catalogued TaqMan (Thermo Fisher Scientific) predesigned gene primer probes attached to the FAM dye were used: PFKFB3 (Hs00998698_m1), GAPDH (Hs02786624_g1), PKM2 (Hs00761782_s1), ATP5B (Hs00969569_m1), CYBA (Hs00609145_m1), CYBB (Hs00166163_m1), NCF1 (Hs00417167_m1) and NCF2 (Hs01084940_m1). 18S (Hs03003631_g1) was used as the reference gene primer, attached to the VIC dye. RT-qPCR was performed using SensiFast Probe Mix (Meridian Biosciences, catalogue BIO-82005) on a QuantStudio 5 RT-qPCR System (Applied Biosystems). Relative quantitative data were obtained and analysed utilizing the 2–ΔΔCt method.
Bacterial Growth Assay
Colony forming units (CFU) were determined at 3, 48 or 120 h post-infection. Cells were lysed with triton-X 100 (0.1 %) and pooled with bacterial pellets (except 3 h) from the centrifugation of supernatants to account for total bacterial burden. Bacteria were diluted in Middlebrook 7H9 broth and plated onto Middlebrook 7H10 agar supplemented with OADC (both Becton Dickinson) and cycloheximide (Merck). Agar plates were incubated at 37 °C and enumerated after 14 days.
PI inclusion Assay
Human MDM were stained with propidium iodide (PI; 5 μg/ml; Merck), and Hoechst 33258 and 33342 (both 50 μg/ml; Merck) at 72 h post-infection with M. avium. Cells were incubated for 30 min at room temperature in the dark. Imaging was performed with a LionHeart FX® Automated Microscope (Agilent) at 10X. The ratio of PI–positive cells to the total number of Hoechst 33258/Hoechst 33242-stained nuclei in 4 fields was determined by the Gen5 software (Biotek) and used to calculate the percentage of cell death.
Cytokine Assays
Concentrations of IL-1β, IL-6, IL-8, IL-10 (BioLegend), and TNF (Invitrogen) in supernatants were quantified by ELISA at 120 h post-infection, according to manufacturer’s protocol.
